Wellington Management Group’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-295,454
| Closed | -$28.7M | – | 2183 |
|
|
2019
Q3 | $28.7M | Buy |
295,454
+18,457
| +7% | +$1.85M | 0.01% | 880 |
|
|
2019
Q2 | $28.4M | Sell |
276,997
-29,607
| -10% | -$3.19M | 0.01% | 926 |
|
|
2019
Q1 | $34.9M | Sell |
306,604
-2,529,067
| -89% | -$186M | 0.01% | 858 |
|
|
2018
Q4 | $111M | Sell |
2,835,671
-2,316,977
| -45% | -$100M | 0.03% | 480 |
|
|
2018
Q3 | $281M | Buy |
5,152,648
+1,611,819
| +46% | +$110M | 0.06% | 309 |
|
|
2018
Q2 | $293M | Sell |
3,540,829
-239,591
| -6% | -$18.5M | 0.07% | 293 |
|
|
2018
Q1 | $252M | Buy |
3,780,420
+663,671
| +21% | +$38.3M | 0.06% | 324 |
|
|
2017
Q4 | $160M | Buy |
3,116,749
+2,239,944
| +255% | +$161M | 0.04% | 420 |
|
|
2017
Q3 | $78.2M | Buy |
876,805
+58,951
| +7% | +$4.48M | 0.02% | 618 |
|
|
2017
Q2 | $48.9M | Buy |
817,854
+9,072
| +1% | +$507K | 0.01% | 745 |
|
|
2017
Q1 | $43.1M | Buy |
808,782
+440,287
| +119% | +$26.1M | 0.01% | 778 |
|
|
2016
Q4 | $18.4M | Sell |
368,495
-147,627
| -29% | -$7.91M | ﹤0.01% | 1030 |
|
|
2016
Q3 | $31M | Buy |
516,122
+123,128
| +31% | +$7.1M | 0.01% | 839 |
|
|
2016
Q2 | $20.1M | Sell |
392,994
-43,238
| -10% | -$1.85M | 0.01% | 945 |
|
|
2016
Q1 | $12.9M | Buy |
436,232
+15,232
| +4% | +$480K | ﹤0.01% | 1065 |
|
|
2015
Q4 | $19.1M | Buy |
421,000
+135,720
| +48% | +$7.11M | 0.01% | 967 |
|
|
2015
Q3 | $11.9M | Sell |
285,280
-219,670
| -44% | -$11.5M | ﹤0.01% | 1125 |
|
|
2015
Q2 | $30.2M | Sell |
504,950
-7,270
| -1% | -$481K | 0.01% | 871 |
|
|
2015
Q1 | $38.4M | Buy |
+512,220
| New | +$29.5M | 0.01% | 815 |
|
Wellington Management Group's ONCE Position: Q4 2019 in Review
Wellington Management Group sold out of Spark Therapeutics, Inc. Common Stock (ONCE) in Q4 2019, closing a stake of 295,454 shares — an estimated $28.7M sold.
Wellington Management Group first reported a position in ONCE in Q1 2015 and held it in 19 quarters. The position peaked at $293M in Q2 2018. 0 funds tracked by Wall St. Rank hold ONCE as of Q4 2019.
- Wellington Management Group reported no remaining Spark Therapeutics, Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
- Wellington Management Group sold 295,454 Spark Therapeutics, Inc. Common Stock shares in Q4 2019, an estimated $28.7M.
- Wellington Management Group first reported a position in Spark Therapeutics, Inc. Common Stock in Q1 2015 and held it in 19 quarters.
- Wellington Management Group's Spark Therapeutics, Inc. Common Stock position peaked at $293M in Q2 2018.
- 0 funds tracked by Wall St. Rank held Spark Therapeutics, Inc. Common Stock as of Q4 2019.
Based on Wellington Management Group's 13F filing for Q4 2019, filed 11 Feb 2020.